Generation of human induced pluripotent stem cell line derived from Becker muscular dystrophy patient with CRISPR/Cas9-mediated correction of DMD gene mutation

被引:0
|
作者
Przymuszala, Marta [1 ,2 ]
Martyniak, Alicja [1 ,2 ]
Kwiatkowska, Joanna [3 ]
Meyer-Szary, Jaros law [3 ]
Sledzinska, Karolina [4 ]
Wierzba, Jolanta [4 ]
Dulak, Jozef [1 ]
Florczyk-Soluch, Urszula [1 ]
Stepniewski, Jacek [1 ]
机构
[1] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Med Biotechnol, Krakow, Poland
[2] Jagiellonian Univ, Doctoral Sch Exact & Nat Sci, Prof St Lojasiewicz 11, PL-30348 Krakow, Poland
[3] Med Univ Gdansk, Dept Paediat Cardiol & Congenital Heart Defects, Gdansk, Poland
[4] Med Univ Gdansk, Dept Paediat Haematol & Oncol, Gdansk, Poland
关键词
Becker muscular dystrophy CRISPR; Cas9; technology;
D O I
10.1016/j.scr.2024.103327
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Becker muscular dystrophy (BMD) is an X-linked recessive disorder caused by in-frame deletions in the dystrophin gene (DMD), leading to progressive muscle degeneration and weakness. We generated a human induced pluripotent stem cell (hiPSC) line from a BMD patient. BMD hiPSCs were then engineered by CRISPR/Cas9mediated knock -in of missing exons 3-9 of DMD gene. Obtained hiPSC line may be a valuable tool for investigating the mechanisms underlying BMD pathogenesis.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Generation of a human induced pluripotent stem cell line (INNDSUi003-A) derived from patient with Becker muscular dystrophy (BMD)
    Ji, Xinbo
    Wang, Yu
    Sun, Ping
    Wang, Dongdong
    Sun, Xiaohan
    Zhang, Rui
    Xu, Jingwen
    Li, Wei
    Liu, Fuchen
    Yan, Chuanzhu
    STEM CELL RESEARCH, 2022, 62
  • [2] Generation of human induced pluripotent stem cell lines with HMOX1 promoter polymorphism and CRISPR/Cas9-mediated deletion of exon 50 of DMD gene
    Polak, Katarzyna
    Stepniewski, Jacek
    Sciezynska, Aneta
    Podgorska, Anna
    Dulak, Jozef
    Florczyk-Soluch, Urszula
    STEM CELL RESEARCH, 2023, 66
  • [3] Reversal of Phenotypic Abnormalities by CRISPR/Cas9-Mediated Gene Correction in Huntington Disease Patient-Derived Induced Pluripotent Stem Cells
    Xu, Xiaohong
    Tay, Yilin
    Sim, Bernice
    Yoon, Su-In
    Huang, Yihui
    Ooi, Jolene
    Utami, Kagistia Hana
    Ziaei, Amin
    Ng, Bryan
    Radulescu, Carola
    Low, Donovan
    Ng, Alvin Yu Jin
    Loh, Marie
    Venkatesh, Byrappa
    Ginhoux, Florent
    Augustine, George J.
    Pouladi, Mahmoud A.
    STEM CELL REPORTS, 2017, 8 (03): : 619 - 633
  • [4] Lab resource: Stem Cell Line Generation of the Becker muscular dystrophy patient derived induced pluripotent stem cell line carrying the DMD splicing mutation c.1705-8 T > C .
    Rovina, Davide
    Castiglioni, Elisa
    Niro, Francesco
    Farini, Andrea
    Belicchi, Marzia
    Di Fede, Elisabetta
    Gervasini, Cristina
    Paganini, Stefania
    Di Segni, Marina
    Torrente, Yvan
    Santoro, Rosaria
    Pompilio, Giulio
    Gowran, Aoife
    STEM CELL RESEARCH, 2020, 45
  • [5] Precise Correction of the Dystrophin Gene in Duchenne Muscular Dystrophy Patient Induced Pluripotent Stem Cells by TALEN and CRISPR-Cas9
    Li, Hongmei Lisa
    Fujimoto, Naoko
    Sasakawa, Noriko
    Shirai, Saya
    Ohkame, Tokiko
    Sakuma, Tetsushi
    Tanaka, Michihiro
    Amano, Naoki
    Watanabe, Akira
    Sakurai, Hidetoshi
    Yamamoto, Takashi
    Yamanaka, Shinya
    Hotta, Akitsu
    STEM CELL REPORTS, 2015, 4 (01): : 143 - 154
  • [6] CRISPR/Cas9-mediated genetic correction of induced pluripotent stem cells from a familial hypercholesterolemia type IIA patient
    Caron, J.
    Luce, E.
    Mainot, S. Goulinet
    Saheb, S.
    Bruckert, E.
    Weber, A.
    Nguyen, T. H.
    Kupperschmitt, A. Dubart
    HUMAN GENE THERAPY, 2016, 27 (11) : A138 - A138
  • [7] CRISPR/Cas9-Mediated Gene Correction in Osteopetrosis Patient-Derived iPSCs
    Li, Dandan
    Ou, Minglin
    Zhang, Wei
    Luo, Qi
    Cai, Wanxia
    Mo, Chune
    Liang, Wenken
    Dai, Guandong
    Yin, Lianghong
    Zhu, Peng
    Tang, Donge
    Dai, Yong
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2023, 28 (06):
  • [8] CRISPR/Cas9-mediated generation of a human induced pluripotent stem cell line with PRPF6 c.2699 G > A mutation to model retinitis pigmentosa
    Liang, Yuqin
    Sun, Xihao
    Chen, Hang
    Cui, Zekai
    Gu, Jianing
    Duan, Chunwen
    Mao, Shengru
    Chen, Yuexi
    Li, Xiaoxue
    Xiong, Siqi
    Chen, Jiansu
    STEM CELL RESEARCH, 2024, 81
  • [9] CRISPR/Cas9-mediated gene correction in hemophilia B patient-derived iPSCs
    Satoshi Morishige
    Shinichi Mizuno
    Hidetoshi Ozawa
    Takayuki Nakamura
    Ahmad Mazahery
    Kei Nomura
    Ritsuko Seki
    Fumihiko Mouri
    Koichi Osaki
    Kenichi Yamamura
    Takashi Okamura
    Koji Nagafuji
    International Journal of Hematology, 2020, 111 : 225 - 233
  • [10] CRISPR/Cas9-mediated gene correction in hemophilia B patient-derived iPSCs
    Morishige, Satoshi
    Mizuno, Shinichi
    Ozawa, Hidetoshi
    Nakamura, Takayuki
    Mazahery, Ahmad
    Nomura, Kei
    Seki, Ritsuko
    Mouri, Fumihiko
    Osaki, Koichi
    Yamamura, Kenichi
    Okamura, Takashi
    Nagafuji, Koji
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2020, 111 (02) : 225 - 233